FDA Warns About Suicide, Delirium Associated with Tamiflu
The U.S. Food and Drug Administration (FDA) added a warning to Tamiflu’s label after repeated reports of self-injury, suicide and delirium associated with the anti-viral drug.
Side effects, including panic attacks, delusions, delirium, convulsions, depression, loss of consciousness, and in some cases, suicide, occurred primarily in children under the age of 17 within a day of taking the drug.
Tamiflu is one of four treatments for seasonal flu in the U.S. It is usually taken to prevent or lessen the severity of the virus.
